Reply: could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?
Options
BORIS DOI
Publisher DOI
PubMed ID
25614435
Date of Publication
2015-01-27
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Siontis, George |
Additional Credits
Series
Journal of the American College of Cardiology
Publisher
Elsevier
ISSN
0735-1097
Access(Rights)
restricted